CAV1 and neoplasm: The aim of our in vitro and in vivo studies was to evaluate the role of Cav-1 in promoting resistance to hormone therapy by upregulating fatty acid synthesis and maintaining tumor growth and to identify the potential therapeutic opportunities created by targeting fatty acid synthesis in Cav-1 expressing mCRPC.